Partial Restoration of Mutant Enzyme Homeostasis in Three Distinct Lysosomal Storage Disease Cell Lines by Altering Calcium Homeostasis
2008

Restoring Enzyme Function in Lysosomal Storage Diseases with Calcium Channel Blockers

publication Evidence: moderate

Author Information

Author(s): Mu Ting-Wei, Fowler Douglas M, Kelly Jeffery W

Primary Institution: The Scripps Research Institute

Hypothesis

Can manipulating calcium homeostasis improve the function of mutant lysosomal enzymes in lysosomal storage diseases?

Conclusion

Diltiazem and verapamil can partially restore the function of mutant lysosomal enzymes in three distinct lysosomal storage diseases by enhancing their folding and trafficking.

Supporting Evidence

  • Diltiazem and verapamil are FDA-approved drugs that enhance the folding and trafficking of mutant lysosomal enzymes.
  • Calcium channel blockers can improve enzyme homeostasis in multiple lysosomal storage diseases.
  • Manipulating calcium levels in cells can help restore function to misfolded proteins.

Takeaway

Some medicines can help sick cells work better by fixing how they handle proteins, which is important for certain diseases.

Methodology

The study used patient-derived fibroblast cell lines to assess the effects of diltiazem and verapamil on mutant enzyme activity.

Limitations

Further studies are needed to confirm clinical utility and safety of the treatments.

Participant Demographics

Fibroblast cell lines from patients with Gaucher disease and other lysosomal storage diseases.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pbio.0060026

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication